Goldman Sachs
NMRA icon

Goldman Sachs’s Neumora Therapeutics NMRA Stock Holding History

Goldman Sachs’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
568,280
-290,222
-34% -$752K ﹤0.01% 5029
2025
Q4 		$1.54M Buy
858,502
+481,128
+127% +$1.05M ﹤0.01% 4810
2025
Q3 		$687K Sell
377,374
-124,795
-25% -$202K ﹤0.01% 5308
2025
Q2 		$368K Sell
502,169
-105,615
-17% -$80K ﹤0.01% 5334
2025
Q1 		$608K Sell
607,784
-33,139
-5% -$56.7K ﹤0.01% 5066
2024
Q4 		$6.79M Buy
640,923
+300,902
+88% +$3.61M ﹤0.01% 3148
2024
Q3 		$4.49M Buy
340,021
+21,564
+7% +$252K ﹤0.01% 3443
2024
Q2 		$3.13M Buy
318,457
+155,878
+96% +$1.61M ﹤0.01% 3579
2024
Q1 		$2.24M Sell
162,579
-429,843
-73% -$6.95M ﹤0.01% 3790
2023
Q4 		$10.1M Buy
592,422
+518,822
+705% +$6.37M ﹤0.01% 2517
2023
Q3 		$1.04M Buy
+73,600
New +$920K ﹤0.01% 4246

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return